April 15, 2020 GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA
April 14, 2020 BONESUPPORT announces CERAMENT in combination with bisphosphonate shows promising results in preclinical long-term study
April 14, 2020 GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa
April 03, 2020 BONESUPPORT HOLDING AB (publ) publishes 2019 Annual Report and comments on effects of COVID-19